Bio Connections Australia

Bio Connections Australia serves as the annual flagship event for the biotech industry, providing a premier platform for networking, discussions, and thought leadership aimed at accelerating the translation of medical research into practical applications. The conference focuses on commercialisation, drug discovery, development, and the promotion of Australia's innovative science on a global stage. It attracts a diverse audience of senior decision-makers from various sectors including pharmaceutical leaders, investors, biotech firms, researchers, CROs, universities, and regulatory bodies, creating a rich environment for collaboration and knowledge exchange.

This year's event features an impressive lineup of speakers, including Dr. Simona John von Freyend, Chief Operating Officer at Inosi Therapeutics, and Dr. Gisela Mautner, CEO of Noxopharm, who will share insights into mRNA innovation and health security. The discussions aim to explore the practical challenges and opportunities in biotechnology, with particular focus on navigating the complexities of commercialization and regulatory processes. The keynotes and panels will delve into various topics such as the transformation of the US biotech landscape and its implications for Australia, investment trends in biotech, and the role of women in biotech leadership.